Nasus Pharma is trading 5.9% lower at $3.28 on October 27, 2026, with no clear catalyst identified.

  • No company-specific announcement explaining the decline appeared in the latest company news or search results; the most recent listed company updates predate October 27.
  • The broader market was mixed to modestly positive in the supplied context, which does not clearly explain the downward move.